You are here

  • Home
  • Archive
  • Volume 5, Issue 3
  • Adherence-adjusted estimates of benefits and harms from treatment with amoxicillin for LRTI: secondary analysis of a 12-country randomised placebo-controlled trial using randomisation-based efficacy estimators

Citation Tools

Article menu
XML
Respiratory medicine
Research
Adherence-adjusted estimates of benefits and harms from treatment with amoxicillin for LRTI: secondary analysis of a 12-country randomised placebo-controlled trial using randomisation-based efficacy estimators

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Gillespie D, Hood K, Farewell D On behalf of the GRACE consortium, et al
Adherence-adjusted estimates of benefits and harms from treatment with amoxicillin for LRTI: secondary analysis of a 12-country randomised placebo-controlled trial using randomisation-based efficacy estimators
BMJ Open 2015;5:e006160. doi: 10.1136/bmjopen-2014-006160